Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Analysis of Liquidity Ratios

Beginner level

Liquidity Ratios (Summary)

Regeneron Pharmaceuticals Inc., liquidity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Current ratio 3.63 3.67 4.47 3.82 2.56
Quick ratio 2.86 2.81 3.50 2.98 2.13
Cash ratio 1.33 1.53 1.95 1.24 0.84

Based on: 10-K (filing date: 2021-02-08), 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Regeneron Pharmaceuticals Inc.’s current ratio deteriorated from 2018 to 2019 and from 2019 to 2020.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Regeneron Pharmaceuticals Inc.’s quick ratio deteriorated from 2018 to 2019 but then slightly improved from 2019 to 2020.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Regeneron Pharmaceuticals Inc.’s cash ratio deteriorated from 2018 to 2019 and from 2019 to 2020.

Current Ratio

Regeneron Pharmaceuticals Inc., current ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Current assets 9,779,100  7,689,100  6,447,600  4,335,030  3,180,188 
Current liabilities 2,697,400  2,096,600  1,442,800  1,135,483  1,241,495 
Liquidity Ratio
Current ratio1 3.63 3.67 4.47 3.82 2.56
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories 1.72 1.44 1.62 2.26 4.02
AbbVie Inc. 0.84 3.18 0.98 1.28 1.65
Amgen Inc. 1.81 1.44 2.79 5.49 4.11
Bristol-Myers Squibb Co. 1.58 1.60 1.61 1.55 1.55
Eli Lilly & Co. 1.40 1.16 1.73 1.32 1.37
Gilead Sciences Inc. 3.10 3.38 2.74 2.22
Illumina Inc. 3.60 6.69 2.49 3.99 3.29
Johnson & Johnson 1.21 1.26 1.47 1.41 2.47
Merck & Co. Inc. 1.02 1.24 1.17 1.33 1.78
Pfizer Inc. 1.35 0.88 1.57 1.35 1.25
Vertex Pharmaceuticals Inc. 4.33 3.61 3.43 3.28 2.31
Zoetis Inc. 3.05 2.63 3.60 3.85 3.03
Current Ratio, Sector
Pharmaceuticals & Biotechnology 1.57 1.73 1.82 2.10
Current Ratio, Industry
Health Care 1.49 1.52 1.61 1.75

Based on: 10-K (filing date: 2021-02-08), 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09).

1 2020 Calculation
Current ratio = Current assets ÷ Current liabilities
= 9,779,100 ÷ 2,697,400 = 3.63

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Regeneron Pharmaceuticals Inc.’s current ratio deteriorated from 2018 to 2019 and from 2019 to 2020.

Quick Ratio

Regeneron Pharmaceuticals Inc., quick ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Cash and cash equivalents 2,193,700  1,617,800  1,467,700  812,733  535,203 
Marketable securities 1,393,300  1,596,500  1,342,200  596,847  503,481 
Accounts receivable, trade, net 3,111,500  2,100,000  1,723,700  1,538,642  1,343,368 
Accounts receivable, Sanofi, net 404,700  260,600  226,400  193,684  92,989 
Accounts receivable, other, net 598,500  311,600  293,100  242,014  175,263 
Total quick assets 7,701,700  5,886,500  5,053,100  3,383,920  2,650,304 
 
Current liabilities 2,697,400  2,096,600  1,442,800  1,135,483  1,241,495 
Liquidity Ratio
Quick ratio1 2.86 2.81 3.50 2.98 2.13
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories 1.14 0.88 1.03 1.67 3.31
AbbVie Inc. 0.60 2.91 0.78 0.89 1.14
Amgen Inc. 1.30 1.01 2.44 4.98 3.68
Bristol-Myers Squibb Co. 1.28 1.26 1.37 1.30 1.27
Eli Lilly & Co. 0.85 0.68 1.20 0.91 0.98
Gilead Sciences Inc. 2.86 3.15 2.52 1.78
Illumina Inc. 3.18 6.00 2.23 3.43 2.75
Johnson & Johnson 0.91 0.94 1.08 1.04 2.04
Merck & Co. Inc. 0.58 0.78 0.72 0.83 1.24
Pfizer Inc. 0.78 0.50 0.84 0.93 0.84
Vertex Pharmaceuticals Inc. 4.02 3.33 3.19 2.94 2.06
Zoetis Inc. 2.13 1.67 2.24 2.34 1.47
Quick Ratio, Sector
Pharmaceuticals & Biotechnology 1.18 1.28 1.41 1.64
Quick Ratio, Industry
Health Care 1.13 1.12 1.24 1.35

Based on: 10-K (filing date: 2021-02-08), 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09).

1 2020 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 7,701,700 ÷ 2,697,400 = 2.86

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Regeneron Pharmaceuticals Inc.’s quick ratio deteriorated from 2018 to 2019 but then slightly improved from 2019 to 2020.

Cash Ratio

Regeneron Pharmaceuticals Inc., cash ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Cash and cash equivalents 2,193,700  1,617,800  1,467,700  812,733  535,203 
Marketable securities 1,393,300  1,596,500  1,342,200  596,847  503,481 
Total cash assets 3,587,000  3,214,300  2,809,900  1,409,580  1,038,684 
 
Current liabilities 2,697,400  2,096,600  1,442,800  1,135,483  1,241,495 
Liquidity Ratio
Cash ratio1 1.33 1.53 1.95 1.24 0.84
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories 0.60 0.38 0.45 1.08 2.82
AbbVie Inc. 0.30 2.56 0.47 0.59 0.66
Amgen Inc. 0.91 0.69 2.17 4.62 3.40
Bristol-Myers Squibb Co. 0.83 0.84 0.83 0.71 0.72
Eli Lilly & Co. 0.29 0.21 0.68 0.55 0.55
Gilead Sciences Inc. 2.50 2.84 2.19 1.29
Illumina Inc. 2.79 5.13 1.95 2.88 2.21
Johnson & Johnson 0.59 0.54 0.63 0.60 1.59
Merck & Co. Inc. 0.30 0.47 0.40 0.46 0.83
Pfizer Inc. 0.47 0.26 0.59 0.66 0.57
Vertex Pharmaceuticals Inc. 3.55 2.85 2.83 2.59 1.81
Zoetis Inc. 1.66 1.07 1.39 1.43 0.65
Cash Ratio, Sector
Pharmaceuticals & Biotechnology 0.81 0.90 1.01 1.23
Cash Ratio, Industry
Health Care 0.73 0.72 0.85 0.94

Based on: 10-K (filing date: 2021-02-08), 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09).

1 2020 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 3,587,000 ÷ 2,697,400 = 1.33

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Regeneron Pharmaceuticals Inc.’s cash ratio deteriorated from 2018 to 2019 and from 2019 to 2020.